Skip to main content

Table 1 Demographic and biochemical characteristics of study participants

From: The role of 14,15-dihydroxyeicosatrienoic acid levels in inflammation and its relationship to lipoproteins

 

CHD patients

Healthy controls

P

 

n=60

n=60

 

Age (years)

60.42±8.75

61.09±8.87

NS

Male/Female

44/16

42/18

NS

BMI (kg/m2)

24.59±3.36

24.63±2.91

NS

Smoking cases (yes/no)

38/22

36/24

NS

TG (mmol/L)

1.75±0.91

1.33±0.68

0.041a

TC (mmol/L)

4.48±1.01

4.19±0.92

NS

HDL-C (mmol/L)

1.04±0.29

1.20±0.28

0.018a

LDL-C (mmol/L)

2.78±1.10

2.24±0.71

0.036a

FBS (mmol/L)

6.49±3.06

5.94±2.79

NS

BUN (mmol/L)

5.51±1.80

5.67±1.40

NS

Cr (umol/L)

81.61±19.33

78.85±16.87

NS

ALT (mmol/L)

24.68±9.99

20.58±8.21

NS

AST (mmol/L)

26.79±9.45

24.24±7.44

NS

ACE inhibitor or ARB (%)

36 (60%)

0 (0%)

 

Beta-blocker (%)

49 (82%)

0 (0%)

 

Statin (%)

60 (100%)

0 (0%)

 

Aspirin (%)

60 (100%)

0 (0%)

 

Clopidogrel (%)

15 (25%)

0 (0%)

 
  1. aP < 0.05; CHD: Coronary heart disease; BMI: body mass index; TG: triglyceride; TC: total cholesterol; HDL-C: high-density lipoprotein cholesterol; LDL-C: low-density lipoprotein cholesterol; FBS: fasting blood glucose; BUN: blood urea nitrogen; Cr: serum creatinine; ALT: alanine aminotransferase; AST: aspartate aminotransferase; NS: not significant.